Author

E. L. Seah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Hurt· 1 shared B. Jin· 1 shared C. M. K. Tai· 1 shared C. Mackenzie-Kludas· 1 shared D. Y. Oh· 1 shared E. Fairmaid· 1 shared J. L. McKimm-Breschkin· 1 shared L. E. Brown· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. C. Hurt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A new concept in antiviral drug design yields a potent influenza inhibitor

C. Mackenzie-Kludas, W.-Y. Wu, B. Jin, J. L. McKimm-Breschkin, E. L. Seah, P. Jones, E. Fairmaid, C. M. K. Tai, D. Y. Oh, P. Jenkins, A. C. Hurt, L. E. Brown

This paper introduces a new antiviral drug design approach that alters the virion surface microenvironment to block influenza virus entry, showing potent in vitro and in vivo activity.

bioRxiv · Nov 8, 2022 · PreprintMicrobiology